Baidu
map

Pediatrics:超声可准确诊断小儿肺炎

2015-03-23 linda 医学论坛网

欲寻求小儿肺炎诊断替代方法的儿科医生或将多一有效诊断方法——肺部超声(LUS)。美国儿科学会会刊《儿科学》(Pediatrics)3月16日在线发布的一项荟萃分析显示,经培训的医生应用LUS诊断肺炎的特异性和灵敏度高。肺炎是导致全球儿童死亡的首位原因。但由于年龄及感染原因各异,患儿呈现的症状也各不相同,因此导致小儿肺炎的诊断尤为困难。此外,部分症状并不能排除小儿肺炎,却可能提示存在其他疾病。医生常

欲寻求小儿肺炎诊断替代方法的儿科医生或将多一有效诊断方法——肺部超声(LUS)。美国儿科学会会刊《儿科学》(Pediatrics)3月16日在线发布的一项荟萃分析显示,经培训的医生应用LUS诊断肺炎的特异性和灵敏度高。

肺炎是导致全球儿童死亡的首位原因。但由于年龄及感染原因各异,患儿呈现的症状也各不相同,因此导致小儿肺炎的诊断尤为困难。此外,部分症状并不能排除小儿肺炎,却可能提示存在其他疾病。医生常应用胸片来辅助诊断肺炎,但其实这往往不准确,而且对医疗资源匮乏的区域而言,费用也极其昂贵。

来自美国马里兰州圣约翰•霍普金斯大学的Maria A. Pereda医学博士及其同事对既往将LUS用于小儿肺炎诊断的研究进行了荟萃分析。他们发现,LUS诊断小儿肺炎的灵敏度达96%,特异性达93%。

“尽管我们的研究表明,专家应用LUS诊断肺炎的灵敏度和特异性最高;但同时也表明非专家级别的医生应用LUS诊断肺炎的准确性也很高。”研究人员称。

相较胸片,LUS诊断具有诸多优势。美国儿科协会建议慎用胸片,因电离辐射对儿童可能存在不良影响,而且胸片阴性的结果并不能排除肺炎的可能。此外,在医疗资源有限的区域未必能实现拍胸片。相反,LUS较低廉,安全,便于携带,且易学。

“建议对普通儿科医生进行LUS小儿肺炎的诊断的培训,在各种临床实践中可能具有重要意义,”研究人员称,“尤其是对于资源匮乏的国家,及不能经常拍胸片的小诊所。”

研究人员也注意到了研究中所存在的一些不足,包括大多数被纳入分析的研究的受试者的样本量少,分析的研究数量也很少。不同研究之间在数据收集及研究实施的方法方面存在明显差异。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1637057, encodeId=33ff163e0575a, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 08 23:34:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64521, encodeId=c4f564521ec, content=超声应用越来越多, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/14/d0501100fdfe783cab0715811e01c133.jpg, createdBy=51ed1602754, createdName=mengli1984, createdTime=Tue Feb 16 21:50:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32613, encodeId=e0d832613d5, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c501632215, createdName=1dd8ea20m15(暂无匿称), createdTime=Mon Jul 13 17:58:00 CST 2015, time=2015-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958411, encodeId=1b9e19584115f, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sun Oct 25 07:34:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056809, encodeId=49272056809e6, content=<a href='/topic/show?id=b19d4693144' target=_blank style='color:#2F92EE;'>#小儿肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46931, encryptionId=b19d4693144, topicName=小儿肺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ba9118, createdName=makuansheng, createdTime=Sat Oct 17 13:34:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725793, encodeId=e2e41e25793ba, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Jun 28 06:34:00 CST 2015, time=2015-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18678, encodeId=571c186e8e3, content=如果真的话,X线就没人用了, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Mar 23 20:07:00 CST 2015, time=2015-03-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1637057, encodeId=33ff163e0575a, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 08 23:34:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64521, encodeId=c4f564521ec, content=超声应用越来越多, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/14/d0501100fdfe783cab0715811e01c133.jpg, createdBy=51ed1602754, createdName=mengli1984, createdTime=Tue Feb 16 21:50:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32613, encodeId=e0d832613d5, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c501632215, createdName=1dd8ea20m15(暂无匿称), createdTime=Mon Jul 13 17:58:00 CST 2015, time=2015-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958411, encodeId=1b9e19584115f, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sun Oct 25 07:34:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056809, encodeId=49272056809e6, content=<a href='/topic/show?id=b19d4693144' target=_blank style='color:#2F92EE;'>#小儿肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46931, encryptionId=b19d4693144, topicName=小儿肺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ba9118, createdName=makuansheng, createdTime=Sat Oct 17 13:34:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725793, encodeId=e2e41e25793ba, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Jun 28 06:34:00 CST 2015, time=2015-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18678, encodeId=571c186e8e3, content=如果真的话,X线就没人用了, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Mar 23 20:07:00 CST 2015, time=2015-03-23, status=1, ipAttribution=)]
    2016-02-16 mengli1984

    超声应用越来越多

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1637057, encodeId=33ff163e0575a, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 08 23:34:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64521, encodeId=c4f564521ec, content=超声应用越来越多, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/14/d0501100fdfe783cab0715811e01c133.jpg, createdBy=51ed1602754, createdName=mengli1984, createdTime=Tue Feb 16 21:50:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32613, encodeId=e0d832613d5, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c501632215, createdName=1dd8ea20m15(暂无匿称), createdTime=Mon Jul 13 17:58:00 CST 2015, time=2015-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958411, encodeId=1b9e19584115f, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sun Oct 25 07:34:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056809, encodeId=49272056809e6, content=<a href='/topic/show?id=b19d4693144' target=_blank style='color:#2F92EE;'>#小儿肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46931, encryptionId=b19d4693144, topicName=小儿肺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ba9118, createdName=makuansheng, createdTime=Sat Oct 17 13:34:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725793, encodeId=e2e41e25793ba, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Jun 28 06:34:00 CST 2015, time=2015-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18678, encodeId=571c186e8e3, content=如果真的话,X线就没人用了, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Mar 23 20:07:00 CST 2015, time=2015-03-23, status=1, ipAttribution=)]
    2015-07-13 1dd8ea20m15(暂无匿称)

    了解了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1637057, encodeId=33ff163e0575a, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 08 23:34:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64521, encodeId=c4f564521ec, content=超声应用越来越多, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/14/d0501100fdfe783cab0715811e01c133.jpg, createdBy=51ed1602754, createdName=mengli1984, createdTime=Tue Feb 16 21:50:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32613, encodeId=e0d832613d5, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c501632215, createdName=1dd8ea20m15(暂无匿称), createdTime=Mon Jul 13 17:58:00 CST 2015, time=2015-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958411, encodeId=1b9e19584115f, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sun Oct 25 07:34:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056809, encodeId=49272056809e6, content=<a href='/topic/show?id=b19d4693144' target=_blank style='color:#2F92EE;'>#小儿肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46931, encryptionId=b19d4693144, topicName=小儿肺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ba9118, createdName=makuansheng, createdTime=Sat Oct 17 13:34:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725793, encodeId=e2e41e25793ba, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Jun 28 06:34:00 CST 2015, time=2015-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18678, encodeId=571c186e8e3, content=如果真的话,X线就没人用了, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Mar 23 20:07:00 CST 2015, time=2015-03-23, status=1, ipAttribution=)]
    2015-10-25 hbwxf
  5. [GetPortalCommentsPageByObjectIdResponse(id=1637057, encodeId=33ff163e0575a, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 08 23:34:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64521, encodeId=c4f564521ec, content=超声应用越来越多, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/14/d0501100fdfe783cab0715811e01c133.jpg, createdBy=51ed1602754, createdName=mengli1984, createdTime=Tue Feb 16 21:50:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32613, encodeId=e0d832613d5, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c501632215, createdName=1dd8ea20m15(暂无匿称), createdTime=Mon Jul 13 17:58:00 CST 2015, time=2015-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958411, encodeId=1b9e19584115f, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sun Oct 25 07:34:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056809, encodeId=49272056809e6, content=<a href='/topic/show?id=b19d4693144' target=_blank style='color:#2F92EE;'>#小儿肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46931, encryptionId=b19d4693144, topicName=小儿肺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ba9118, createdName=makuansheng, createdTime=Sat Oct 17 13:34:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725793, encodeId=e2e41e25793ba, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Jun 28 06:34:00 CST 2015, time=2015-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18678, encodeId=571c186e8e3, content=如果真的话,X线就没人用了, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Mar 23 20:07:00 CST 2015, time=2015-03-23, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1637057, encodeId=33ff163e0575a, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 08 23:34:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64521, encodeId=c4f564521ec, content=超声应用越来越多, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/14/d0501100fdfe783cab0715811e01c133.jpg, createdBy=51ed1602754, createdName=mengli1984, createdTime=Tue Feb 16 21:50:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32613, encodeId=e0d832613d5, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c501632215, createdName=1dd8ea20m15(暂无匿称), createdTime=Mon Jul 13 17:58:00 CST 2015, time=2015-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958411, encodeId=1b9e19584115f, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sun Oct 25 07:34:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056809, encodeId=49272056809e6, content=<a href='/topic/show?id=b19d4693144' target=_blank style='color:#2F92EE;'>#小儿肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46931, encryptionId=b19d4693144, topicName=小儿肺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ba9118, createdName=makuansheng, createdTime=Sat Oct 17 13:34:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725793, encodeId=e2e41e25793ba, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Jun 28 06:34:00 CST 2015, time=2015-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18678, encodeId=571c186e8e3, content=如果真的话,X线就没人用了, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Mar 23 20:07:00 CST 2015, time=2015-03-23, status=1, ipAttribution=)]
    2015-06-28 feather89
  7. [GetPortalCommentsPageByObjectIdResponse(id=1637057, encodeId=33ff163e0575a, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 08 23:34:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64521, encodeId=c4f564521ec, content=超声应用越来越多, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/14/d0501100fdfe783cab0715811e01c133.jpg, createdBy=51ed1602754, createdName=mengli1984, createdTime=Tue Feb 16 21:50:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32613, encodeId=e0d832613d5, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c501632215, createdName=1dd8ea20m15(暂无匿称), createdTime=Mon Jul 13 17:58:00 CST 2015, time=2015-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958411, encodeId=1b9e19584115f, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sun Oct 25 07:34:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056809, encodeId=49272056809e6, content=<a href='/topic/show?id=b19d4693144' target=_blank style='color:#2F92EE;'>#小儿肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46931, encryptionId=b19d4693144, topicName=小儿肺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ba9118, createdName=makuansheng, createdTime=Sat Oct 17 13:34:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725793, encodeId=e2e41e25793ba, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Jun 28 06:34:00 CST 2015, time=2015-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18678, encodeId=571c186e8e3, content=如果真的话,X线就没人用了, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Mar 23 20:07:00 CST 2015, time=2015-03-23, status=1, ipAttribution=)]
    2015-03-23 lovetcm

    如果真的话,X线就没人用了

    0

相关资讯

STS 2015:CABG时输血增加肺炎风险

2015年美国心胸外科学会(STS)年会上的一项研究数据显示,单独的冠状动脉旁路移植术(CABG)中或之后输注红细胞的患者,术后发生肺炎风险增加。 密歇根大学健康系统 Donald S. Likosky博士指出,“CABG后肺炎是已知的危险,且肺炎可增加患者的发病和死亡风险。既往研究已表明,每20例接受CABG的患者就有1例发生主要感染,而肺炎是最常见类型的感染。” 该研究于201

Pediatrics:注射疫苗帮助儿童战胜肺炎

肺炎链球菌是肺炎的主要致病菌,肺炎每年引起超过1百万的儿童死亡。而鼻窦炎也能导致儿童肺炎,甚至引起眼睛和颅内感染。尽管肺炎链球菌疫苗(PCV)可以有效抵御肺炎链球菌的侵入,但是它对能否有效防止肺炎还是个未知数。为了研究PCV疫苗与肺炎的关系,瑞典公共健康机构的Ann Lindstrand医生比较了PCV7和PCV13疫苗接种前后鼻窦炎、肺炎和脓胸的住院率。研究对象为2003-2012年瑞典斯德哥尔

Lancet:泼尼松附加治疗“利刃已现”

一项瑞士研究显示,在经验性抗生素治疗的基础上,泼尼松附加治疗可缩短社区获得性肺炎住院患者入院至达到临床病情稳定的时间,且不增加并发症发生风险。论文1月18日在线发表于《柳叶刀》(Lancet)杂志。 此项双盲、多中心、随机、安慰剂对照试验共纳入785例18岁以上的社区获得性肺炎患者,来自瑞士7所24小时开放的三级医院。研究者将患者随机等分为两组:泼尼松治疗组(50mg/d,口服7

Lancet Infect Dis:五岁以下儿童肺炎临床诊断特征

在发展中国家肺炎是导致儿童死亡最大的因素,但早期诊断和干预能有效降低死亡率。我们旨在评估临床症状和体征诊断价值,并以此来临床指征在判定5岁以下儿童患放射性肺炎时的诊断价值以及审查WHO临床肺炎诊断标准的准确性 。 我们搜索了Medline (PubMed), Embase (Ovid), the Cochrane Database of Systematic Reviews, and refer

欧盟批准辉瑞肺炎疫苗Prevenar 13(沛儿13)用于18岁及以上成人群体

辉瑞(Pfizer)重磅疫苗产品Prevenar 13(沛儿13)近日在欧盟监管方面收获大好消息。欧盟委员会(EC)已批准扩大Prevenar 13适应症,用于18岁及以上成人群体,预防由13种血清型肺炎链球菌株导致的肺炎。Prevenar 13的产品特性概要(SPC)也已更新,纳入了辉瑞具有里程碑意义的CAPiTA(社区获得性肺炎成人免疫试验)研究的疗效数据,表明接种Prevenar 13显

JAMA:糖皮质激素或可用于重症社区获得性肺炎急性期治疗

在发达国家,社区获得性肺炎在导致死亡的感染性中占主导地位。尽管积极的使用抗感染治疗,因其导致的住院病人死亡率依旧居高不下,尤其是重症肺炎和治疗失败的情况下。而重症社区获得性肺炎的病人,其治疗失败通常与进行性炎症反应和更糟糕的临床结局有关。在这类治疗失败的病人中,可以使用糖皮质激素,去调节体内细胞因子的释放以抵抗炎症反应,达到治疗效果,但是目前对于糖皮质激素在这类人群中的运用仍存在争议。因此Anto

Baidu
map
Baidu
map
Baidu
map